Does the BCO1 rs7501331 T allele reduce beta-carotene conversion to vitamin A?

The BCO1 gene encodes the primary enzyme responsible for converting plant-derived beta-carotene into active vitamin A. The rs7501331 T allele significantly impairs this metabolic pathway, shifting dietary requirements.

Clinical evidence and metabolic impact

• Carrying a single rs7501331 T allele reduces beta-carotene-to-vitamin A conversion efficiency by approximately 32%.
• When combined with the rs12934922 variant, conversion capacity drops dramatically by 57% to 69%, resulting in lower active retinoid yield and higher circulating beta-carotene.
• Because standard Retinol Activity Equivalents (RAEs) overestimate vitamin A status in these "low converters," carriers have an increased physiological reliance on preformed dietary vitamin A (retinol and retinyl esters) from animal sources or supplements.

Mechanistic explanations

• The rs7501331 variant is a missense mutation causing an alanine-to-valine (A379V) substitution, which directly lowers the catalytic efficiency ($V_{max}$) of the beta-carotene 15,15'-monooxygenase enzyme.
• This impaired cleavage causes beta-carotene to accumulate in the blood, increasing the risk of hypercarotenemia.
• In the eyes, this metabolic bottleneck is associated with an 18% reduction in macular pigment optical density (MPOD), indicating altered retinal carotenoid status.

Bottom line

• Bottom line: The BCO1 rs7501331 T allele decreases beta-carotene conversion efficiency by 32% to 69%, creating a physiological requirement for preformed vitamin A from animal products or supplements to prevent subclinical deficiency and support macular health.